|
|
|
Xtalks, Online
2024-11-01
Pandemic preparedness is a continual process to ensure that when the need arises, drug developers, industry partners and government agencies can come together to proactively address emerging public health threats.
Close and careful coordination across stakeholders is vital to successfully addressing emergent and present threats to public health, especially when response is needed on a global scale. Key to preparation is the advanced identification of resource gaps and strategic response blind spots. This introspective analysis is critical to creating a strong foundation for robust pandemic response strategy by enabling the early identification of partners who can effectively support response efforts.
Coordinating with multiple partners, especially in times of crisis and uncertainty, is not without its challenges. This webinar will explore how a full-service clinical research organization (CRO) having contract development and manufacturing organization (CDMO) capabilities approaches pandemic preparedness to ensure a comprehensive and coordinated response with the necessary agility and speed to address public health emergencies.
The expert speakers will discuss how they can collaborate to expedite therapeutic and vaccine development when time is of the absolute essence and share real-world examples and lessons learned.
Register for this webinar today to learn how to enhance pandemic preparedness by establishing relevant partnerships that can help expedite therapeutic and vaccine development.
Keywords: Drug Development, Pandemic, Clinical Research, CRO, Patient Recruitment, Clinical Operations, Diagnostics, Laboratory Technology, Pandemic Preparedness, Sites, CDMO/CMO
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
Invited Speakers:
|
|
Dr. Vanessa Elharrar, MD, MPH, Global Medical Officer, Vaccines and Government and Public Health Services, PPD Clinical Research Business of Thermo Fisher Scientific Olivia Aspite, Executive Director, Lab Operations, PPD Clinical Research Business of Thermo Fisher Scientific Jennifer Crager, Executive Director, Digital Implementation, Patient First Digital Solutions, PPD Clinical Research Business of Thermo Fisher Scientific Allison Grande, Senior Business Development Manager, Public Health, Thermo Fisher Scientific Kelly Howard, VP, Commercial Operations, VVS Global & Advanced Therapies, Thermo Fisher Scientific Dr. Lisa Kierstead, Executive Director, Vaccines Lab, PPD Clinical Research Business of Thermo Fisher Scientific Pam Launt, Executive Director, Biostatistics & Programming, PPD Clinical Research Business of Thermo Fisher Scientific Dr. Debra Schaumberg, VP and Global Head, Strategic Development Consulting, PPD Clinical Research Business of Thermo Fisher Scientific
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-11-01
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|